SCHEMBL21744417

SCHEMBL21744417

O=C(NC1CCN(c2cccc3c2CCNC3)CC1)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.51
CA2 P00918 2/20 0.51
ACHE P22303 2/20 0.51
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
CTSL P07711 1/20 0.48
CTSB P07858 1/20 0.48
CTSK P43235 1/20 0.48
TSHR P16473 1/20 0.47
TMEM97 Q5BJF2 2/20 0.44
SIGMAR1 Q99720 2/20 0.44
HSD11B1 P28845 1/20 0.44
EPHX1 P07099 1/20 0.44
DPP4 P27487 4/20 0.44
DPP7 Q9UHL4 4/20 0.44
KCNH2 Q12809 3/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GPR55 Q9Y2T6 1/20 0.43
F13A1 P00488 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16142089 0.76 TGM2 (0.52) ACHEALDH1A1GAACTSLCTSB
Hydrochloric Acid SCHEMBL16113083 0.75 TGM2 (0.51) ACHEALDH1A1GAACTSLCTSB
SCHEMBL13402357 0.74 ALDH1A1 (0.67) CA1CA2ACHEALDH1A1GAA
SCHEMBL7617 0.74 ALDH1A1 (0.70) CA1CA2ACHEALDH1A1GAA
SCHEMBL21744166 0.74 ALDH1A1 (0.47) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL31334311 0.73 ALDH1A1 (0.58) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL21744165 0.73 CD44 (0.46) KCNH2MEN1KMT2A
Hydrochloric Acid SCHEMBL605486 0.73 ALDH1A1 (0.68) CA1CA2ACHEALDH1A1GAA
SCHEMBL3948456 0.72 ALDH1A1 (0.85) CA1CA2ACHEALDH1A1GAA
SCHEMBL3948461 0.72 ALDH1A1 (0.85) CA1CA2ACHEALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto UNIV EMORY (US) 2023-04-13 US disclosed
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto EMORY UNIVERSITY 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 CA1 4182/4885CA2 2879/4885ACHE 4295/4885
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 CA1 4182/4885CA2 2879/4885ACHE 4295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.